3/30
01:18 pm
jnj
Johnson & Johnson (JNJ) had its "outperform" rating reaffirmed by Royal Bank Of Canada. They now have a $255.00 price target on the stock.
Low
Report
Johnson & Johnson (JNJ) had its "outperform" rating reaffirmed by Royal Bank Of Canada. They now have a $255.00 price target on the stock.
3/30
09:29 am
jnj
The Low-Volatility Promise of ACWV Costs Investors 118% Over a Decade Compared to SPY [Yahoo! Finance]
Low
Report
The Low-Volatility Promise of ACWV Costs Investors 118% Over a Decade Compared to SPY [Yahoo! Finance]
3/30
07:26 am
jnj
Royalty Pharma Announces R&D Funding Collaboration for Chronic Immune-Mediated Diseases [Yahoo! Finance]
Low
Report
Royalty Pharma Announces R&D Funding Collaboration for Chronic Immune-Mediated Diseases [Yahoo! Finance]
3/29
01:37 pm
jnj
AtaiBeckley Weighs BPL-003 Deal After Strong Phase 2a And FDA Support [Yahoo! Finance]
Low
Report
AtaiBeckley Weighs BPL-003 Deal After Strong Phase 2a And FDA Support [Yahoo! Finance]
3/28
08:08 pm
jnj
Johnson & Johnson Oncology And Immunology Advances Test Valuation Story [Yahoo! Finance]
Low
Report
Johnson & Johnson Oncology And Immunology Advances Test Valuation Story [Yahoo! Finance]
3/28
10:28 am
jnj
ICOTYDE™ (icotrokinra) one-year results confirm lasting skin clearance and favorable safety profile in once-daily pill for plaque psoriasis [Yahoo! Finance]
Low
Report
ICOTYDE™ (icotrokinra) one-year results confirm lasting skin clearance and favorable safety profile in once-daily pill for plaque psoriasis [Yahoo! Finance]
3/28
10:00 am
jnj
ICOTYDE™ (icotrokinra) one-year results confirm lasting skin clearance and favorable safety profile in once-daily pill for plaque psoriasis
Low
Report
ICOTYDE™ (icotrokinra) one-year results confirm lasting skin clearance and favorable safety profile in once-daily pill for plaque psoriasis
3/28
04:48 am
jnj
New SPRAVATO® (esketamine nasal spray) data support robust effectiveness and show durable effect for treatment resistant depression in a real-world setting [Yahoo! Finance]
Low
Report
New SPRAVATO® (esketamine nasal spray) data support robust effectiveness and show durable effect for treatment resistant depression in a real-world setting [Yahoo! Finance]
3/28
12:31 am
jnj
Brazil Digestive Remedies Market to Reach USD 1.11 Billion by 2032, Says Vyansa Intelligence [Yahoo! Finance]
Low
Report
Brazil Digestive Remedies Market to Reach USD 1.11 Billion by 2032, Says Vyansa Intelligence [Yahoo! Finance]
3/27
04:21 pm
jnj
Cue Biopharma names Lucinda Warren as interim CEO [Seeking Alpha]
Low
Report
Cue Biopharma names Lucinda Warren as interim CEO [Seeking Alpha]
3/27
12:08 pm
jnj
Why Income Investors Keep VTV as a Core Portfolio Anchor in a Turbulent 2026 [Yahoo! Finance]
Low
Report
Why Income Investors Keep VTV as a Core Portfolio Anchor in a Turbulent 2026 [Yahoo! Finance]
3/27
06:03 am
jnj
Amazon's Big Spring Sale: Top deals under $50 from Sony, Cuisinart, Swiffer and more [FOX News]
Low
Report
Amazon's Big Spring Sale: Top deals under $50 from Sony, Cuisinart, Swiffer and more [FOX News]
3/26
09:19 am
jnj
15 small Amazon buys that make life easier, starting at $4 [FOX News]
Low
Report
15 small Amazon buys that make life easier, starting at $4 [FOX News]
3/25
09:44 pm
jnj
Johnson & Johnson: Deserves A Place In Conservative Dividend Growth Portfolios [Seeking Alpha]
Low
Report
Johnson & Johnson: Deserves A Place In Conservative Dividend Growth Portfolios [Seeking Alpha]
3/25
06:46 pm
jnj
Arsenio Hall's career from 'Coming to America' to late-night legend [USA TODAY]
Low
Report
Arsenio Hall's career from 'Coming to America' to late-night legend [USA TODAY]
3/24
02:40 pm
jnj
Johnson & Johnson Targets Procedure Growth With Bladder Cancer And Vision Advances [Yahoo! Finance]
Low
Report
Johnson & Johnson Targets Procedure Growth With Bladder Cancer And Vision Advances [Yahoo! Finance]
3/24
01:52 pm
jnj
Gilead acquires first TCE asset with $2.2bn Ouro Medicines buyout [Yahoo! Finance]
Low
Report
Gilead acquires first TCE asset with $2.2bn Ouro Medicines buyout [Yahoo! Finance]
3/24
01:37 pm
jnj
Martin Cobb's Top Picks for March 24, 2026 [BNN Bloomberg (Canada)]
Low
Report
Martin Cobb's Top Picks for March 24, 2026 [BNN Bloomberg (Canada)]
3/24
10:20 am
jnj
Golfweek Masters Survey: Favorite picture from Augusta National [USA TODAY]
Low
Report
Golfweek Masters Survey: Favorite picture from Augusta National [USA TODAY]
3/24
08:50 am
jnj
Protagonist Partners With Johnson & Johnson To Compete With AbbVie's Skyrizi [Seeking Alpha]
Low
Report
Protagonist Partners With Johnson & Johnson To Compete With AbbVie's Skyrizi [Seeking Alpha]
3/24
07:39 am
jnj
Johnson & Johnson (JNJ) Advances Bladder Cancer Treatment with 89% Response Rate [Yahoo! Finance]
Low
Report
Johnson & Johnson (JNJ) Advances Bladder Cancer Treatment with 89% Response Rate [Yahoo! Finance]
3/22
08:10 pm
jnj
???????????????????? : ???????????????2035??3?3534?????? CAGR9%??????????????????????????? [CNET News]
Low
Report
???????????????????? : ???????????????2035??3?3534?????? CAGR9%??????????????????????????? [CNET News]
3/21
06:21 pm
jnj
Protagonist Therapeutics Soars as FDA Approves ICOTYDE for Plaque Psoriasis, Triggers $50M Milestone [Yahoo! Finance]
Low
Report
Protagonist Therapeutics Soars as FDA Approves ICOTYDE for Plaque Psoriasis, Triggers $50M Milestone [Yahoo! Finance]
3/21
03:55 pm
jnj
Jim Cramer on Johnson & Johnson: “It's a Textbook Slowdown Stock” [Yahoo! Finance]
Low
Report
Jim Cramer on Johnson & Johnson: “It's a Textbook Slowdown Stock” [Yahoo! Finance]
3/21
01:17 pm
jnj
Pulse Biosciences Touts 96% 12-Month Rhythm Control, Targets Q2 Start for U.S. AF IDE Study [Yahoo! Finance]
Low
Report
Pulse Biosciences Touts 96% 12-Month Rhythm Control, Targets Q2 Start for U.S. AF IDE Study [Yahoo! Finance]